VC-backed Kuros merges with listed Cytos
Life Sciences Partners-backed Swiss biotechnology company Kuros has merged with Cytos, a listed biopharmaceutical company, thereby entering the Swiss stock exchange.
More on Portfolio management
PlusServer owner BC Partners seeks sale via Jefferies as loan maturity looms
GP acquired the German cloud solutions group in 2017 via BC European Capital X
Volpi raises EUR 250m continuation vehicle for 2016-vintage assets
Volpi Capital Investments Conti will hold Dutch geospatial data company Cyclomedia and UK-based surveillance group Digital Barriers
The Bolt-Ons Digest – 17 April 2023
Unquote’s selection of the latest add-ons with Triton's BFC Group, Seven2's Groupe Crystal, Palatine's FourNet and more
MJ Hudson business divisions acquired by Apex Group
Sale follows suspension of listed UK-headquartered asset management service provider’s shares in December 2022
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater